DOVER, Del. (AP) — The Delaware House voted Thursday to approve a bill legalizing possession of up to one ounce of marijuana by adults for recreational use.
The legislation cleared the Democrat-led House on 26-14 vote and now goes to the Senate, which is also controlled by Democrats. Even if it were to pass both chambers, it faces a potential veto from Democratic Gov. John Carney, who has previously expressed doubts about legalizing recreational marijuana.
Under current law, possession of one ounce or less of marijuana by anyone 21 years of age or older carries a civil penalty of $100. That provision would be eliminated under the bill approved Thursday.
Possession of recreational marijuana by anyone under 21 would still result in a civil penalty, while possession of more than one ounce of marijuana and public consumption would remain misdemeanors.
The bill approved Thursday was introduced in late March as stand-alone legislation after a failed effort to pass broader legislation creating a state-regulated and taxed marijuana industry.
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Advocates of legalizing recreational marijuana in South Dakota, a mission with a rocky history, submitted thousands of signatures to election officials on Tuesday in the hopes of once again getting…
Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…
By Aaron Pelley, Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…
The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…